172 related articles for article (PubMed ID: 16350577)
1. Androgen treatment of abdominally obese men.
Mårin P; Holmäng S; Gustafsson C; Jönsson L; Kvist H; Elander A; Eldh J; Sjöström L; Holm G; Björntorp P
Obes Res; 1993 Jul; 1(4):245-51. PubMed ID: 16350577
[TBL] [Abstract][Full Text] [Related]
2. Testosterone and regional fat distribution.
Mårin P
Obes Res; 1995 Nov; 3 Suppl 4():609S-612S. PubMed ID: 8697064
[TBL] [Abstract][Full Text] [Related]
3. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men.
Mårin P; Holmäng S; Jönsson L; Sjöström L; Kvist H; Holm G; Lindstedt G; Björntorp P
Int J Obes Relat Metab Disord; 1992 Dec; 16(12):991-7. PubMed ID: 1335979
[TBL] [Abstract][Full Text] [Related]
4. Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity.
Bhasin S; Parker RA; Sattler F; Haubrich R; Alston B; Umbleja T; Shikuma CM;
J Clin Endocrinol Metab; 2007 Mar; 92(3):1049-57. PubMed ID: 17164307
[TBL] [Abstract][Full Text] [Related]
5. Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues.
Mårin P; Krotkiewski M; Björntorp P
Eur J Med; 1992 Oct; 1(6):329-36. PubMed ID: 1341460
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of dihydrotestosterone treatment on prostate growth in healthy, middle-aged men without prostate disease: a randomized, placebo-controlled trial.
Idan A; Griffiths KA; Harwood DT; Seibel MJ; Turner L; Conway AJ; Handelsman DJ
Ann Intern Med; 2010 Nov; 153(10):621-32. PubMed ID: 21079217
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure.
Johannsson G; Mårin P; Lönn L; Ottosson M; Stenlöf K; Björntorp P; Sjöström L; Bengtsson BA
J Clin Endocrinol Metab; 1997 Mar; 82(3):727-34. PubMed ID: 9062473
[TBL] [Abstract][Full Text] [Related]
8. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
9. Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels.
Bhasin S; Storer TW; Asbel-Sethi N; Kilbourne A; Hays R; Sinha-Hikim I; Shen R; Arver S; Beall G
J Clin Endocrinol Metab; 1998 Sep; 83(9):3155-62. PubMed ID: 9745419
[TBL] [Abstract][Full Text] [Related]
10. Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men.
Lovejoy JC; Bray GA; Greeson CS; Klemperer M; Morris J; Partington C; Tulley R
Int J Obes Relat Metab Disord; 1995 Sep; 19(9):614-24. PubMed ID: 8574271
[TBL] [Abstract][Full Text] [Related]
11. Testosterone with dutasteride, but not anastrazole, improves insulin sensitivity in young obese men: a randomized controlled trial.
Juang PS; Peng S; Allehmazedeh K; Shah A; Coviello AD; Herbst KL
J Sex Med; 2014 Feb; 11(2):563-73. PubMed ID: 24344872
[TBL] [Abstract][Full Text] [Related]
12. The effects of transdermal dihydrotestosterone in the aging male: a prospective, randomized, double blind study.
Kunelius P; Lukkarinen O; Hannuksela ML; Itkonen O; Tapanainen JS
J Clin Endocrinol Metab; 2002 Apr; 87(4):1467-72. PubMed ID: 11932266
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial.
Franco C; Brandberg J; Lönn L; Andersson B; Bengtsson BA; Johannsson G
J Clin Endocrinol Metab; 2005 Mar; 90(3):1466-74. PubMed ID: 15598680
[TBL] [Abstract][Full Text] [Related]
14. Low concentrations of insulin-like growth factor-I in abdominal obesity.
Mårin P; Kvist H; Lindstedt G; Sjöström L; Björntorp P
Int J Obes Relat Metab Disord; 1993 Feb; 17(2):83-9. PubMed ID: 8384169
[TBL] [Abstract][Full Text] [Related]
15. The metabolic effects of preferential reduction of visceral adipose tissue in abdominally obese men.
Marks SJ; Chin S; Strauss BJ
Int J Obes Relat Metab Disord; 1998 Sep; 22(9):893-8. PubMed ID: 9756248
[TBL] [Abstract][Full Text] [Related]
16. Dihydrotestosterone administration does not increase intraprostatic androgen concentrations or alter prostate androgen action in healthy men: a randomized-controlled trial.
Page ST; Lin DW; Mostaghel EA; Marck BT; Wright JL; Wu J; Amory JK; Nelson PS; Matsumoto AM
J Clin Endocrinol Metab; 2011 Feb; 96(2):430-7. PubMed ID: 21177791
[TBL] [Abstract][Full Text] [Related]
17. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women.
Morales AJ; Haubrich RH; Hwang JY; Asakura H; Yen SS
Clin Endocrinol (Oxf); 1998 Oct; 49(4):421-32. PubMed ID: 9876338
[TBL] [Abstract][Full Text] [Related]
18. No specific effect of fluoxetine treatment on fasting glucose, insulin, lipid levels, and blood pressure in healthy men with abdominal obesity.
Visser M; Seidell JC; Koppeschaar HP; Smits P
Obes Res; 1994 Mar; 2(2):152-9. PubMed ID: 16353616
[TBL] [Abstract][Full Text] [Related]
19. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.
Wang C; Cunningham G; Dobs A; Iranmanesh A; Matsumoto AM; Snyder PJ; Weber T; Berman N; Hull L; Swerdloff RS
J Clin Endocrinol Metab; 2004 May; 89(5):2085-98. PubMed ID: 15126525
[TBL] [Abstract][Full Text] [Related]
20. Influence of methyltestosterone postmenopausal therapy on plasma lipids, inflammatory factors, glucose metabolism and visceral fat: a randomized study.
Leão LM; Duarte MP; Silva DM; Bahia PR; Coeli CM; de Farias ML
Eur J Endocrinol; 2006 Jan; 154(1):131-9. PubMed ID: 16382002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
